Navigation Links
Medicines Used In Antiplatelet Therapy Can Reduce Heart Attacks And Strokes

Research shows that using antiplatelet medication called clopidogrel before coronary angioplasty surgery often reduces the risk of death from cardiovascular problems like heart attacks, or strokes.// The research paper was published in the latest issue of JAMA.

Dual antiplatelet therapy following percutaneous coronary intervention using a combination of drugs such as ticlopidine or clopidogrel along with aspirin helps reduce platelet activation and thrombotic and ischemic complications. However, the optimal timing of the initiation of clopidogrel has been debated. The benefit of clopidogrel pretreatment started hours to days before PCI compared with treatment given at the time of PCI in high-risk patients with acute coronary syndromes remains incompletely defined, and current guidelines do not universally recommend pretreatment.

Researchers from Harvard Medical School, Boston, had conducted a study to determine if clopidogrel pretreatment hours to days before PCI is superior to clopidogrel treatment initiated at the time of PCI in preventing major adverse cardiovascular events in patients undergoing PCI after initial pharmacological therapy for ST-segment elevation myocardial infarction.

. The study included an analysis of 1,863 patients undergoing PCI after mandated angiography for STEMI. Patients received aspirin and were randomized to receive either clopidogrel (300 mg loading dose [a comparatively large dose given at the beginning of treatment to start getting the effect of a drug more quickly], then 75 mg once daily) or placebo initiated with fibrinolysis and given until coronary angiography, which was performed 2 to 8 days after initiation of the study drug.

The researchers found that pretreatment with clopidogrel significantly reduced by 46 percent the odds of cardiovascular death, heart attack, or stroke following PCI (34 events [3.6 percent] vs. 58 events [6.2 percent].

Pretreatment with clopidogrel also
'"/>




Page: 1 2

Related medicine news :

1. Medicines on the move
2. Advent of New, More Effective and Personalized Medicines
3. Be Wary Of Heavy Metal Poisoning From Ayurvedic Medicines
4. Metal In Medicines Can Fight Diseases Effectively
5. Heart Patients More At Risk Get Fewer Medicines
6. Export Of Ayurvedic Medicines Affected Due To High Heavy Metal Content
7. Herbal Medicines with Animal, Human Body Parts! - Swami Ramdev Accused
8. Syrupy Medicines Increase the Risk of Tooth Decay
9. Anticholinergic Medicines Result In Cognitive Impairment
10. Wake Up Call: U.N Takes Stock to Curb Fake Medicines Racket
11. Health Minister Promises Strict Quality Control On Herbal Medicines
Post Your Comments:
(Date:7/26/2008)...device giving patients freedom of movement, better...HealthDay News) -- An automated artificial kidney ...alysis patients what the insulin pump is to diabet...al kidney (AWAK) works better than conventional di...of Clinical and Experimental Nephrology . , "W...
(Date:7/25/2008)....Y., July 25 /PRNewswire-USNewswire/ -- Anthony Sh...ty Officer and Vice President,of Strategic Plannin..., a,national foundation committed to improving U.S... foundation,s Program on Health Care Quality,Impro...m.com/cgi-bin/prnh/20080725/DC28791LOGO ), Board...
(Date:7/25/2008)...ponse after antiretroviral therapy may be due to g...thDay News) -- A new study challenges the long-hel...the immune system,s ability to restore itself afte...retroviral therapy (HAART). , From 50 percent t...nfected with HCV. Intravenous drug use is the main...
(Date:7/25/2008)...ffers patients consumers tips and encourages them ...HARRISBURG, Pa., July 25 /PRNewswire-USNewswire/ -...supports "National Patient Safety Day" which,is a ...milies to,participate fully in their healthcare by... about their surgery or illness., "We understand ...
Breaking Medicine News(10 mins):Health News:IPRO Welcomes Back Anthony Shih as Chief Quality Officer, Strategic Planning Lead 2Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3
...ith high-risk genes could increase their chances o...David Goldgar // at the International Agency for R...He found that women with BRCA1 and 2 (breast cance...had undergone a chest X-ray were 54 percent more l...
...il (ACC) and UNICEF have renewed their internation... under which they will support// the global campai...AIDS'. The two bodies will also promote the right...eation and promote girls' education in South Asia,...
...?gren’s (SHOW-grins) syndrome was found to be the ...or long periods. Typical signs and symptoms inclu...y vision, a dry mouth that causes difficulty swall...tid glands. The parotids are a pair of salivary gl...
... Clinic Health Center have identified and announce... Dermatitis, an allergic disease with red, sore it...ike chemicals, medications, certain plants, jewell...ls, creams, etc. The July issue of Mayo Clinic He...
Other Medicine News:
(Date:7/23/2008)...Body Have Greater Concentrations of,Stem Cells, A...wire/ -- Fat removed,from the lower abdomen and in...xcellent source of stem cells, with higher stem ce...ports a Brazilian-based study in August,s,Plastic ...l journal of the,American Society of Plastic Surge...
(Date:7/23/2008)...k with Protein Therapeutics that Modulat...IDGE, Mass., July 23 /- Taligen Thera...rporate growth plan with the,appointment of Abbie ...e,establishment of its headquarters in Cambridge, ...a co-founder of the company who remains president....
(Date:7/22/2008)...- Nonin Medical, a leading innovator,of physiologi...as entered,the clinical testing phase with its bre...turation. Today,s most common application for this...gional blood oxygenation,in the brain -- cerebral ...n ongoing clinical study at the,Duke University Me...
(Date:7/22/2008)...fficacy of Treating Patients with ... YONGIN-SI, South Korea, July 22 /-,J...io), and its South,Korean partner Green Cross Corp...e I clinical trial of its first-in-class lead prod...tolerated and resulted in clear,anti-cancer effica...
Breaking Medicine Technology:Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4USP Convention and Chinese Pharmacopoeia Commission sign Memorandum of Understanding 2430 1USP Convention and Chinese Pharmacopoeia Commission sign Memorandum of Understanding 2430 2U of I researcher develops power packed soy breakfast cereal 2428 1U of I researcher develops power packed soy breakfast cereal 2428 2AACN Applauds Senator Richard Durbin for Introducing the Troops to Nurse Teachers Act of 2008 13710 1AACN Applauds Senator Richard Durbin for Introducing the Troops to Nurse Teachers Act of 2008 13710 2AACN Applauds Senator Richard Durbin for Introducing the Troops to Nurse Teachers Act of 2008 13710 3United Mitochondrial Disease Foundation Statement on Vaccines Autism and Mitochondrial Disease 13708 1
...e People with Diabetes, Hospital,and Professional ...PITTSBURGH, April 02, 2007 /PRNewswire-FirstCall/ ...announced today the,release of a new report on the...with Type 2 diabetes. The inaugural Pittsburgh Typ...of patient,demographics, hospital and professional...
...archers report that a,variation in a portion of DN...this common variation may be responsible for up to...in the United States.,The research was conducted b... (NCI), part of the National Institutes of Health,...of Susceptibility,(CGEMS) initiative. CGEMS resear...
Other Medicine Technology:State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 2State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 3State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 4Researchers Discover a Common Variation in a Gene Segment that,Increases the Risk for Prostate Cancer 2Researchers Discover a Common Variation in a Gene Segment that,Increases the Risk for Prostate Cancer 3Researchers Discover a Common Variation in a Gene Segment that,Increases the Risk for Prostate Cancer 4
...ly adjustable dispensing head, and disposable, pre...aralleled flexibility and cost-efficiency to micro... of its kind to offer fast dispensing of fluids in...lso offers the added benefit of being able to acco...
The WellPro 384 is designed for use with 384 well microplates. It utilizes a 24 channel liquid head and can perform serial dilutions in a 16 or 24 across format, and plate to plate transfers and plat
The Labcyte Echo 550 compound reformatter performs direct microplate-to-microplate transfers of droplets down to 5 nL using a new "touchless" transfer technology based on focused acoustic energy. Mon
Precise, nanoliter-volume liquid handling capability allows you to accurately dispense volumes as small as 5 nanoliters. Precision robotics and flexible software ensure accurate, repeatable X/Y motio
Medicine Products: